Von-Willebrand-Jürgens syndrome
Winckelmann, G.
Medizinische Klinik 68(2): 37-42
1973
ISSN/ISBN: 0025-8458 PMID: 4567798 Document Number: 62974
Document emailed within 1 workday
Related Documents
Schulz, K.; Engelmann, C.; Kaben, H. 1973: Diagnosis of the von-Willebrand-Jürgens syndrome Zeitschrift für Arztliche Fortbildung 67(12): 622-627Lutze, G.; Canzler, E.; Franke, D.; Töpfer, G. 1989: Pre- and postpartum hemostasis in type Ii Willebrand-Jürgens syndrome Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 44(4): 117-120
Reuter, H.; Tilsner, V. 1978: Two-dimensional immunoelectrophoresis for the determination of factor-VIII-associated protein. Variation in the von Willebrand-Jürgens syndrome Die Medizinische Welt 29(25): 1053-1055
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Kuznetsov, A.I.; Kuz'menko, L.G.; Motina, A.G. 1971: Willebrand-Jürgens disease in an 8-month-old girl Pediatriia 50(8): 83
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Ikehata, K.; Kawauchi, S.; Kohno, F.; Nishiyama, M.; Ide, N. 1980: Increased platelet function and von Willebrand factor in vibration syndrome Tokushima Journal of Experimental Medicine 27(1-2): 23-28
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Kobayashi, N.; Gonmori, H. 1979: Acquired von Willebrand's syndrome-with special reference to its clinical characteristics and pathogenesis Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 883-891
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Komada, T.; Kawasaki, T.; Sata, T. 2013: Anesthetic management of emergency cesarean section in a patient with acquired von Willebrand syndrome Masui. Japanese Journal of Anesthesiology 62(11): 1368-1371